BioCryst Pharmaceuticals, Inc.
NASDAQ: BCRX
$12.52
+$0.41 (+3.4%)
Closing price September 27, 2022
Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and Teva...
1 month ago
Friday's top analyst upgrades and downgrades included AppLovin, BioCryst Pharmaceuticals, Boeing, CF Industries, Coupa Software, Crocs, Dutch Bros, DigitalOcean, Gilead Sciences, IBM, International...
4 months ago
Last Updated: 4 months ago
Monday’s additional top analyst upgrades and downgrades included Aptiv, BioCryst Pharmaceuticals, CSX, Gap, Nektar Therapeutics, Progressive, Peloton Interactive, Sirius XM and United Airlines.
5 months ago
Monday's top analyst upgrades and downgrades included Alibaba, AT&T, Baidu, Bilbili, CommScope, JetBlue Airways, Navient, Nvidia, Pinduoduo, Schlumberger, Sea, State Street, Truist Financial, U.S....
5 months ago
Last Updated: 5 months ago
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Affirm, BioCryst Pharmaceuticals, Exxon Mobile, First Solar and Tesla.
1 year ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
1 year ago
Ford, General Electric and these other stocks are likely to survive the current troubles and could very well offer patient investors some huge returns over the next year or so.
2 years ago
Last Updated: 2 years ago
Tuesday's top analyst upgrades and downgrades included AppFolio, BioCryst Pharmaceuticals, Booking, DraftKings, Intuit, L Brands, Peloton Interactive, Salesforce.com and Wells Fargo.
2 years ago
Last Updated: 2 years ago
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
2 years ago
Last Updated: 2 years ago
The Wuhan Coronavirus has escaped China, with the number of cases and the death toll rising. The economic impact beyond the loss of life and suffering is real in many stocks, sectors and local...
2 years ago
Last Updated: 1 year ago
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the economic...
2 years ago
Last Updated: 1 year ago
BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients.
3 years ago
Last Updated: 2 years ago
Every week we search for stocks covered by top Wall Street analysts that are trading under the $10 level and could provide solid upside potential. This week we found five companies covered by...
3 years ago
Last Updated: 2 years ago
Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and could provide investors with some solid upside potential.
3 years ago
Last Updated: 2 years ago
BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.
4 years ago
Last Updated: 2 years ago